Register for email alerts and news feeds:
This journal | BMJ Group
rss
Published Online First: 13 May 2007. doi:10.1136/hrt.2006.098053
Heart 2007;93:1226-1230
Copyright © 2007 BMJ Publishing Group Ltd & British Cardiovascular Society

ACUTE CORONARY SYNDROMES

Effect of drug combinations on admission for recurrent myocardial infarction

Menno E van der Elst1, Marcel L Bouvy2, Cornelis J de Blaey1, Anthonius de Boer1

1 Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands
2 SIR Institute for Pharmacy Practice and Policy, Leiden, The Netherlands

Dr M L Bouvy, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Sorbonnelaan 16, 3584 CA Utrecht, The Netherlands; m.l.bouvy{at}uu.nl

ABSTRACT

Objective: To determine the effect of the number of different drugs with adherence to medication of at least 70% on recurrent admission for myocardial infarction (MI) in patients with a history of MI.

Design: Nested case–control study in a dynamic cohort.

Setting: PHARMO database that contains pharmacy dispensing records and hospital discharge records of 350 000 Dutch citizens.

Subjects: All patients admitted to hospital for first MI (ICD-9 410) from 1991 to 2000 with at least a 30-day survival after admission. Cases were admitted for recurrent MI and were matched for age, sex, and year of admission with controls who did not have a recurrent MI.

Main outcome measure(s): Odds ratio with 95% CI for admission for recurrent MI. Exposure was the number of preventive drugs (antiplatelet agents, statins and ß blockers or ACE inhibitors) used for at least 70% of the time.

Results: 389 cases were matched with 2344 controls. The use of one drug was associated with a 6% odds reduction (95% CI 30% reduction to 28% increase) for admission for recurrent MI. The use of two or three drugs was associated with reductions of 26% and 41% (47% reduction to 3% increase and 6% to 63% reduction, respectively). Addition of one drug caused a 16% reduction (4% to 26%).

Conclusions: Multiple drug treatment decreases admissions for recurrent MI in patients with a history of MI. Every addition of a drug, regardless of drug class, reduces the risk even further. These results support the treatment strategies as applied in daily practice.

Abbreviations: CABG, coronary artery bypass grafting; CHF, chronic heart failure; MI, myocardial infarction; OR, odds ratio; PDC, percentage of days covered; PTCA, percutaneous transluminal coronary angioplasty

Keywords: myocardial infarction; secondary prevention; combination drug therapy


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Meijs, M F L, Bots, M L, Cramer, M J M, Vonken, E-J A, Velthuis, B K, van der Graaf, Y, Visseren, F L, Mali, W P T. M, Doevendans, P A, on behalf of the SMART Study group, (2009). Unrecognised myocardial infarction in subjects at high vascular risk: prevalence and determinants. Heart 95: 728-732 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.